Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
7-Phenyl-pyrido[2,3-d]pyrimidine-2,4-diamines: novel and highly selective protein tyrosine phosphatase 1B inhibitors.
Cheung AW, Banner B, Bose J, Kim K, Li S, Marcopulos N, Orzechowski L, Sergi JA, Thakkar KC, Wang BB, Yun W, Zwingelstein C, Berthel S, Olivier AR. Cheung AW, et al. Among authors: zwingelstein c. Bioorg Med Chem Lett. 2012 Dec 15;22(24):7518-22. doi: 10.1016/j.bmcl.2012.10.035. Epub 2012 Oct 16. Bioorg Med Chem Lett. 2012. PMID: 23122867
Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
Gillespie P, Pietranico-Cole S, Myers M, Bilotta JA, Conde-Knape K, Fotouhi N, Goodnow RA Jr, Guertin KR, Hamilton MM, Haynes NE, Liu B, Qi L, Ren Y, Scott NR, So SS, Spence C, Taub R, Thakkar K, Tilley JW, Zwingelstein C. Gillespie P, et al. Among authors: zwingelstein c. Bioorg Med Chem Lett. 2014 Jun 15;24(12):2707-11. doi: 10.1016/j.bmcl.2014.04.049. Epub 2014 Apr 21. Bioorg Med Chem Lett. 2014. PMID: 24815509
Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists.
Gillespie P, Goodnow RA Jr, Saha G, Bose G, Moulik K, Zwingelstein C, Myers M, Conde-Knape K, Pietranico-Cole S, So SS. Gillespie P, et al. Among authors: zwingelstein c. Bioorg Med Chem Lett. 2014 Feb 1;24(3):949-53. doi: 10.1016/j.bmcl.2013.12.063. Epub 2013 Dec 24. Bioorg Med Chem Lett. 2014. PMID: 24412066
The emerging role of the intestine in metabolic diseases.
Bradley WD, Zwingelstein C, Rondinone CM. Bradley WD, et al. Among authors: zwingelstein c. Arch Physiol Biochem. 2011 Jul;117(3):165-76. doi: 10.3109/13813455.2011.578651. Arch Physiol Biochem. 2011. PMID: 21671708 Review.
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma.
Weathers SP, Rood-Breithaupt J, de Groot J, Thomas G, Manfrini M, Penas-Prado M, Puduvalli VK, Zwingelstein C, Yung WKA. Weathers SP, et al. Among authors: zwingelstein c. Neurooncol Adv. 2021 Oct 2;3(1):vdab141. doi: 10.1093/noajnl/vdab141. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34693288 Free PMC article.
Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment.
Dale GE, Halabi A, Petersen-Sylla M, Wach A, Zwingelstein C. Dale GE, et al. Among authors: zwingelstein c. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00490-18. doi: 10.1128/AAC.00490-18. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 30012756 Free PMC article. Clinical Trial.
The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease.
Schmitt EK, Riwanto M, Sambandamurthy V, Roggo S, Miault C, Zwingelstein C, Krastel P, Noble C, Beer D, Rao SP, Au M, Niyomrattanakit P, Lim V, Zheng J, Jeffery D, Pethe K, Camacho LR. Schmitt EK, et al. Among authors: zwingelstein c. Angew Chem Int Ed Engl. 2011 Jun 20;50(26):5889-91. doi: 10.1002/anie.201101740. Epub 2011 May 11. Angew Chem Int Ed Engl. 2011. PMID: 21563281 No abstract available.
23 results